financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Wns (holdings) Limited
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Wns (holdings) Limited
May 1, 2024 5:59 AM

08:35 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

WNS printed Mar-Q adj-EPS of $1.12 vs. $1.04 a year ago, beating consensus by $0.06. Revenues (less repair payments) were$326M, +7% Y/Y, as increases in new clients (nine in Mar-Q) and broadening existing client relationships (40) were partially tampered with by transitioning a large internet client's work offshore, in addition to volume reductions with certain clients. Adj-operating margins expanded to 21.5% from 20.6% Y/Y. Despite challenging economic conditions, our rating remains Buy as we believe more companies will be looking to cut costs, playing into WNS's strengths. An improving pipeline positions WNS for outsized growth as demand for business transformation that leverages digital and analytics capabilities increases. We see adj-revenue of $1.35B (+5%) in FY 2025 (Mar-Q) and $1.49B (+10%) in FY 2026. Our 12-month target of $57 (down $23), 11.2x our FY 2026 (Mar-Q) EPS, is aligned with three-year historical averages. We lower our FY 2025 EPS view to $4.56 from $4.71 and initiate FY 2026's at $5.08.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Research Alert: CFRA Raises Opinion On Shares Of Johnson & Johnson To Buy From Hold
Oct 14, 2025
11:05 AM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Q3 earnings and the announcement of the separation of Orthopedics, we raise our target to $220 from $166. This is based on 19.2x our 2026 EPS estimate and is...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Jpmorgan Chase & Co.
Oct 14, 2025
12:20 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $340, applying a forward P/E of 15.5x, near the three-year historical average at 15.0x on normalized earnings. We keep our EPS estimates at...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Blackrock, Inc.
Oct 14, 2025
12:30 AM EDT, 10/15/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price by $95, to $1,340, valuing BLK shares at 22x our newly initiated 2027 adjusted EPS estimate of $60.50, and at 25x our 2026 EPS...
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of The Goldman Sachs Group
Oct 14, 2025
02:40 PM EDT, 10/14/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price at $850, applying a forward P/E of 15.6x our 2026 earnings estimate compared to the five-year historical average for normalized EPS at 15.5x. We...
Copyright 2023-2026 - www.financetom.com All Rights Reserved